Advance patient health in 2025. At ARx, we are committed to patient-centered healthcare development. Our team works constantly to bring the benefits of our dosage forms – enhanced bioavailability, first-pass effect bypass, controlled dosing, rapid onset – to bear for your molecule and your patients. Choose the pioneers in drug delivery this year ➡️ https://arxpharma.com/ #DrugDelivery #DrugManufacturing #PatientCentered
ARx, LLC
Pharmaceutical Manufacturing
Glen Rock, Pennsylvania 3,525 followers
Patient-friendly, alternative drug delivery systems through Oral Thin Films and Transdermal Patches.
About us
ARx is a full-service partner for pharmaceutical and biopharma companies. We specialize in developing novel, innovative drug delivery systems through Oral Thin Films and Transdermal Patches that improve control, bioavailability, and patient experience, expanding therapeutic potential and redefining what’s possible for patients. As one of the first pioneers in polymer science and alternative dosing strategies, we’ve not only shaped modern drug delivery through newer, better standards for quality and safety-but continue to advance them, one product at a time.
- Website
-
http://www.arxpharma.com
External link for ARx, LLC
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Glen Rock, Pennsylvania
- Type
- Privately Held
- Founded
- 2005
- Specialties
- Oral Thin Films, Buccal, Sublingual and Mucosal Thin Films, Transdermal Patches, and Topical Patches
Locations
-
Primary
400 Seaks Run Rd
Glen Rock, Pennsylvania 17327, US
Employees at ARx, LLC
Updates
-
✨ Team ARx wishes you Happy Holidays! ✨ As the year comes to a close, we want to express our gratitude for your trust and partnership. It's been a privilege to support your mission of delivering critical medications with care and precision. This holiday season, we remain committed to timely, safe, and reliable drug delivery—because the health and well-being of our patients is always our top priority. 💊🎁 Wishing you all peace, joy, and good health in 2025!🌟
-
We don't chase trends. We engineer the technology and science to create them. We've never been a company that goes after the "next big thing." Innovation here starts with the patient and with the science – steady, reliable, measured. That’s how we developed MicroDEP, our patented methodology for delivering rapid onset of ultra-low doses through oral thin film. And that’s why we built our Artemis IP platform, with APIs and products vetted in the lab and ready for co-development or licensing. Read about our pharma solutions 👋 https://arxpharma.com/ #DrugDelivery #PharmaSolutions #FDAApproved #Clinical
-
We succeed when you succeed. ✅ Our team is dedicated to understanding the life cycle of a drug and making sure our strategic partnership is to your advantage. The core of our mission is to bring life-changing therapies to market, then meet that ongoing demand. Meet your drug delivery partner ➡️ https://arxpharma.com/ #DrugDelivery #OralThinFilm #Pharma #FDA
-
Facing pharma manufacturing challenges? Meet the experts in oral thin films and transdermal patches. We know that no matter the development stage, volume, or market, your unique product needs to meet strict standards for quality, consistency and patient experience – in a timely manner. At ARx, we carefully source raw materials from vetted suppliers, minimizing potential downtime and delays. Our oral thin film and transdermal patch production is done in-house in our FDA-approved campus, with everything done exactly to your specifications. Need a drug delivery partner? Let's talk 🔗 https://arxpharma.com/ #DrugDelivery #Pharma #TransdermalPatches #OralThinFilms
-
Solving patient challenges with novel drug delivery. ✅ At ARx, we work relentlessly to maximize your molecule's potential—whether you're refining an existing drug or developing something entirely new. We can help you reformulate, improve and deliver. We're full service, with a bigger purpose. Meet your new partner in drug delivery systems ➡️ https://arxpharma.com/ #DrugDelivery #DrugManufacturing
-
Happy Thanksgiving from all of us at ARx! 🦃🍂 This season, we're grateful for our dedicated team, innovative partners, and the opportunity to improve lives through our advanced drug delivery systems. Your trust inspires us to continue pushing boundaries in pharmaceutical technology. As we gather with family and friends, let’s also remember those who rely on our work for better health. Together, we're making a difference! Wishing you a warm and joyful Thanksgiving!
-
Your product, your way. ✅ No matter the development stage, the volume, or the market, your product needs to meet strict standards for quality, consistency, and patient experience. With millions of doses under our belt, ARx delivers exactly that – every time. We carefully source raw materials from vetted suppliers, minimizing potential downtime and delays. Production, from clinical to commercial scale, is done in-house at our FDA-approved campus in Glen Rock, PA. And everything – from formulation to packaging – is done exactly to your specifications. Meet your drug delivery partner 👋 https://arxpharma.com/ #DrugDelivery #PharmaSolutions #FDAApproved #Clinical
-
🍩🚚 Showing our team appreciation with a sweet treat! 🍩🚚 As a small token of appreciation, the ARx team was treated to fresh donuts from our favorite food truck earlier this week! It’s one way of saying thank you to the incredible people who make this company shine every day. Your hard work, passion, and dedication are what make us great, and we’re so grateful for each one of you!
-
"Oral thin film, sublingual, buccal, and transdermal patches are pigeonholed." Enter ARx. 🧑⚕️ We believe in the potential of these dosage forms, and we're structured to help make it a reality. Our focus, scientific credentials, FDA-approved facility, proprietary technologies, and partnership mentality make us your ideal partner to translate new or existing APIs into novel, exciting delivery systems. Expand your therapeutic horizons with ARx ➡️ https://arxpharma.com/ #DrugDelivery #OralThinFilm #Pharma #FDA